These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1919651

  • 1. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.
    García-Rodríguez JA, García Sánchez JE, Muñoz Bellido JL, García Sánchez E, García García MI.
    J Chemother; 1991 Jun; 3(3):143-6. PubMed ID: 1919651
    [Abstract] [Full Text] [Related]

  • 2. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA, Blazquez AM, Fresnadillo MJ, Garcia Sanchez E, Garcia Sanchez JE, Trujillano Martin I.
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [Abstract] [Full Text] [Related]

  • 4. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I, Kaynar-Tascioglu J, Kaya B, Goktas P.
    Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP, Pitkin DH, Sheikh W, Nadler HL.
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F, Quentin C.
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipseudomonal antimicrobials.
    Voutsinas D, Mavroudis T, Avlamis A, Giamarellou H.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():143-7. PubMed ID: 2509412
    [Abstract] [Full Text] [Related]

  • 9. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ.
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
    Sader HS, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [Abstract] [Full Text] [Related]

  • 12. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y, Abe M, Ono N, Araki M, Horimi T, Takahashi I.
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [Abstract] [Full Text] [Related]

  • 13. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Oct; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 14. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K, Ishida A, Chinzei T.
    Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095
    [Abstract] [Full Text] [Related]

  • 15. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
    Lang C, Beuth J, Ko HL, Tunggal L, Pulverer G.
    Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
    [Abstract] [Full Text] [Related]

  • 16. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
    Piddock LJ, Turner HL.
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
    [Abstract] [Full Text] [Related]

  • 17. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J, Calderón C, Sierra MP, Alvarez M, Cantón R.
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [Abstract] [Full Text] [Related]

  • 18. [The antimicrobial susceptibilities and serotypes of Pseudomonas aeruginosa isolated from sputum].
    Fujiue Y, Kuwabara M, Muroki K, Shimizu S, Watanabe Y, Awaya Y, Kodomari Y.
    Jpn J Antibiot; 1998 Jan; 51(1):26-36. PubMed ID: 9557274
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
    Bonfiglio G, Carciotto V, Russo G, Stefani S, Schito GC, Debbia E, Nicoletti G.
    J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
    [Abstract] [Full Text] [Related]

  • 20. Multicenter in vitro evaluation of SM-7338, a new carbapenem.
    Jones RN, Aldridge KE, Allen SD, Barry AL, Fuchs PC, Gerlach EH, Pfaller MA.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):562-5. PubMed ID: 2658796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.